149 related articles for article (PubMed ID: 29234152)
1. LncRNA SPRY4-IT was concerned with the poor prognosis and contributed to the progression of thyroid cancer.
Zhou H; Sun Z; Li S; Wang X; Zhou X
Cancer Gene Ther; 2018 Feb; 25(1-2):39-46. PubMed ID: 29234152
[TBL] [Abstract][Full Text] [Related]
2. Upregulation of the long non-coding RNA SPRY4-IT1 indicates a poor prognosis and promotes tumorigenesis in ovarian cancer.
Li H; Liu C; Lu Z; Chen L; Wang J; Li Y; Ma H
Biomed Pharmacother; 2017 Apr; 88():529-534. PubMed ID: 28129625
[TBL] [Abstract][Full Text] [Related]
3. High expression of long non-coding RNA SPRY4-IT1 predicts poor prognosis of clear cell renal cell carcinoma.
Zhang HM; Yang FQ; Yan Y; Che JP; Zheng JH
Int J Clin Exp Pathol; 2014; 7(9):5801-9. PubMed ID: 25337221
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of the long non-coding RNA SPRY4-IT1 promotes tumor cell proliferation and invasion by activating EZH2 in hepatocellular carcinoma.
Zhou M; Zhang XY; Yu X
Biomed Pharmacother; 2017 Jan; 85():348-354. PubMed ID: 27899259
[TBL] [Abstract][Full Text] [Related]
5. Long noncoding RNA SPRY4-IT1 predicts poor patient prognosis and promotes tumorigenesis in gastric cancer.
Peng W; Wu G; Fan H; Wu J; Feng J
Tumour Biol; 2015 Sep; 36(9):6751-8. PubMed ID: 25835973
[TBL] [Abstract][Full Text] [Related]
6. EZH2-mediated epigenetic suppression of long noncoding RNA SPRY4-IT1 promotes NSCLC cell proliferation and metastasis by affecting the epithelial-mesenchymal transition.
Sun M; Liu XH; Lu KH; Nie FQ; Xia R; Kong R; Yang JS; Xu TP; Liu YW; Zou YF; Lu BB; Yin R; Zhang EB; Xu L; De W; Wang ZX
Cell Death Dis; 2014 Jun; 5(6):e1298. PubMed ID: 24967960
[TBL] [Abstract][Full Text] [Related]
7. Upregulated long non-coding RNA SPRY4-IT1 predicts dismal prognosis for pancreatic ductal adenocarcinoma and regulates cell proliferation and apoptosis.
Yao Y; Gao P; Chen L; Wang W; Zhang J; Li Q; Xu Y
Gene; 2018 Jun; 659():52-58. PubMed ID: 29551494
[TBL] [Abstract][Full Text] [Related]
8. Increased expression of SPRY4-IT1 predicts poor prognosis and promotes tumor growth and metastasis in bladder cancer.
Zhao XL; Zhao ZH; Xu WC; Hou JQ; Du XY
Int J Clin Exp Pathol; 2015; 8(2):1954-60. PubMed ID: 25973088
[TBL] [Abstract][Full Text] [Related]
9. Decreased long noncoding RNA SPRY4-IT1 contributing to gastric cancer cell metastasis partly via affecting epithelial-mesenchymal transition.
Xie M; Nie FQ; Sun M; Xia R; Liu YW; Zhou P; De W; Liu XH
J Transl Med; 2015 Aug; 13():250. PubMed ID: 26238992
[TBL] [Abstract][Full Text] [Related]
10. Upregulation of long noncoding RNA SPRY4-IT1 promotes metastasis of esophageal squamous cell carcinoma via induction of epithelial-mesenchymal transition.
Zhang CY; Li RK; Qi Y; Li XN; Yang Y; Liu DL; Zhao J; Zhu DY; Wu K; Zhou XD; Zhao S
Cell Biol Toxicol; 2016 Oct; 32(5):391-401. PubMed ID: 27250657
[TBL] [Abstract][Full Text] [Related]
11. Decreased long non-coding RNA SPRY4-IT1 contributes to ovarian cancer cell metastasis partly via affecting epithelial-mesenchymal transition.
Yu J; Han Q; Cui Y
Tumour Biol; 2017 Jul; 39(7):1010428317709129. PubMed ID: 28691641
[TBL] [Abstract][Full Text] [Related]
12. The long noncoding RNA SPRY4-IT1 increases the proliferation of human breast cancer cells by upregulating ZNF703 expression.
Shi Y; Li J; Liu Y; Ding J; Fan Y; Tian Y; Wang L; Lian Y; Wang K; Shu Y
Mol Cancer; 2015 Feb; 14():51. PubMed ID: 25742952
[TBL] [Abstract][Full Text] [Related]
13. Long noncoding RNA SPRY4-IT1 is upregulated in esophageal squamous cell carcinoma and associated with poor prognosis.
Xie HW; Wu QQ; Zhu B; Chen FJ; Ji L; Li SQ; Wang CM; Tong YS; Tuo L; Wu M; Liu ZH; Lv J; Shi WH; Cao XF
Tumour Biol; 2014 Aug; 35(8):7743-54. PubMed ID: 24810925
[TBL] [Abstract][Full Text] [Related]
14. Long noncoding RNA SPRY4-IT1 is a prognostic factor for poor overall survival and has an oncogenic role in glioma.
Zhou Y; Wang DL; Pang Q
Eur Rev Med Pharmacol Sci; 2016 Jul; 20(14):3035-9. PubMed ID: 27460732
[TBL] [Abstract][Full Text] [Related]
15. Long non-coding RNA SPRY4-IT1 promotes gallbladder carcinoma progression.
Yang L; Cheng X; Ge N; Guo W; Feng F; Wan F
Oncotarget; 2017 Jan; 8(2):3104-3110. PubMed ID: 27902971
[TBL] [Abstract][Full Text] [Related]
16. Long non-coding RNA SPRY4-IT1 promotes proliferation and invasion by acting as a ceRNA of miR-101-3p in colorectal cancer cells.
Jin J; Chu Z; Ma P; Meng Y; Yang Y
Tumour Biol; 2017 Jul; 39(7):1010428317716250. PubMed ID: 28720069
[TBL] [Abstract][Full Text] [Related]
17. Knockdown of long noncoding RNA SPRY4-IT1 suppresses glioma cell proliferation, metastasis and epithelial-mesenchymal transition.
Liu H; Lv Z; Guo E
Int J Clin Exp Pathol; 2015; 8(8):9140-6. PubMed ID: 26464658
[TBL] [Abstract][Full Text] [Related]
18. Long non-coding RNA SPRY4-IT1 promotes development of hepatic cellular carcinoma by interacting with ERRĪ± and predicts poor prognosis.
Yu G; Lin J; Liu C; Hou K; Liang M; Shi B
Sci Rep; 2017 Dec; 7(1):17176. PubMed ID: 29214989
[TBL] [Abstract][Full Text] [Related]
19. LncRNA SPRY4-IT1 sponges miR-101-3p to promote proliferation and metastasis of bladder cancer cells through up-regulating EZH2.
Liu D; Li Y; Luo G; Xiao X; Tao D; Wu X; Wang M; Huang C; Wang L; Zeng F; Jiang G
Cancer Lett; 2017 Mar; 388():281-291. PubMed ID: 27998761
[TBL] [Abstract][Full Text] [Related]
20. Upregulated long noncoding RNA SPRY4-IT1 contributes to increased cell viability by activating zinc finger 703 expression in esophageal squamous cell carcinoma.
Xue-Liang J; Ming-Dong W; Ya-Bi Z; Wang-Yue W
Indian J Cancer; 2015 Dec; 52 Suppl 3():E164-7. PubMed ID: 27453415
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
